Titan Pharmaceuticals
TTNP
#10330
Rank
HK$47.86 M
Marketcap
HK$35.98
Share price
-3.76%
Change (1 day)
15.08%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.26. In 2023 the company made an earnings per share (EPS) of -HK$57.84 an increase over its 2022 EPS that were of -HK$118.56.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.84-51.22%
2022-HK$118.56-15.61%
2021-HK$140.49-81.37%
2020-HK$753.98-77.52%
2019-HK$3,355-56.32%
2018-HK$7,680-59.51%
2017-HK$18,971-371.81%
2016HK$6,979-144.35%
2015-HK$15,735300%
2014-HK$3,934-121.54%
2013HK$18,264-151.38%
2012-HK$35,545-11.54%
2011-HK$40,181188.89%
2010-HK$13,909-10%
2009-HK$15,454
2007-HK$63,363-2.38%
2006-HK$64,908-39.13%
2005-HK$106,635-16.87%
2004-HK$128,271-22.43%
2003-HK$165,3624.9%
2002-HK$157,63561.9%
2001-HK$97,363-13.7%
2000-HK$112,81765.01%
1999-HK$68,371-35.87%
1998-HK$106,617-1824.71%
1997HK$6,182-102.4%
1996-HK$258,088

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$86.93-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.45-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.08-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.95-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.38-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA